Thermo Fisher Scientific has launched a series of solutions and co-marketing agreements in proteomics.
Specifically, Thermo Fisher:
- Extended its co-marketing agreement with Biognosys, a developer of solutions for plasma analysis. The PQ500 Reference Peptide Kit from Biognosys quantifies more than 500 proteins in human plasma/serum samples as part of the SureQuant IS-PRM workflow, enabled with the Thermo Scientific Orbitrap Exploris 480 mass spectrometer.
- Launched the Thermo Scientific Vanquish Neo Ultra-High Performance Liquid Chromatography (UHPLC) System. The new system is designed for high-sensitivity LC-MS applications.
- Acquired Belgium-based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µPAC portfolio of columns enhance LC performance in biomarker, proteomics and drug research and development applications.
- Signed a co-marketing agreement with Cellenion for a sample preparation solution, cellenONE, that combines single-cell isolation and nanoliter dispensing to perform every step of sample preparation using a single device.
